Overview
Hiroaki Nakanishi practices practicing medicine in Hongo, Japan.
His clinical expertise encompasses Sudden Infant Death Syndrome (SIDS) and Coronary Artery Spasm.
He is actively involved in clinical research, co-authoring 42 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Hiroaki Nakanishi
Is Hiroaki Nakanishi a top-rated expert for Sudden Infant Death Syndrome (SIDS)?
MediFind is an objective health platform that identifies experts based on real-world data. Hiroaki Nakanishi is classified as an Experienced expert for Sudden Infant Death Syndrome (SIDS), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Hiroaki Nakanishi participate in research or clinical trials?
Yes. Hiroaki Nakanishi has published 42 articles and abstracts on conditions like Sudden Infant Death Syndrome (SIDS). You can view a list of Hiroaki Nakanishi's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Coronary Artery SpasmMr. Nakanishi isExperienced. Learn about Coronary Artery Spasm.
- Sudden Infant Death Syndrome (SIDS)Mr. Nakanishi isExperienced. Learn about Sudden Infant Death Syndrome (SIDS).